Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Retatrutide is a top-down metabolic regulator
Product Specifications Laboratory Handling Store lyophilised vials at -20C for long-term stability, protected from light and moisture
Retatrutide is an investigational peptide drug developed by Eli Lilly that acts as a triple agonist, simultaneously targeting three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Our signature IV infusions deliver hydration, vitamins, and nutrients directly to your bloodstream for 100% absorption
US$ 25.33
US$ 28.65
US$ 20.66
US$ 21.32
US$ 21.08
US$ 22.38
US$ 29.63
US$ 28.67
US$ 25.73
US$ 27.69
